In this study, the authors used flow cytometric analysis of patient-derived xenografts to identify cell-surface targets enriched in pancreatic cancer cells, one of which was CDCP1 (referred to as CD318). This evidence concerns the gene CDCP1 and familial pancreatic carcinoma.